News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Graceway Pharmaceuticals, LLC Buys Derma Molecule Rights from Pfizer Inc.
July 6, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
pehub.com -- Graceway Pharmaceuticals LLC, a portfolio company of GTCR Golder Rauner, has agreed to acquire the global commercial rights to three investigational dermatological molecules from Pfizer. No financial terms were disclosed.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Pfizer
MORE ON THIS TOPIC
Artificial intelligence
Genentech makes $1.5B+ deal with AI heavyweight Earendil for cancer bispecifics
September 25, 2026
·
2 min read
·
Tristan Manalac
Deals
Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs
September 24, 2026
·
2 min read
·
Gabrielle Masson
China
Lilly sets aside up to $3.25B to tackle critical unmet need targets with InnoCare
September 24, 2026
·
1 min read
·
Tristan Manalac
Venture capital
AI drug hunter Enveda raises $311M for late-stage obesity, inflammatory disease push
September 23, 2026
·
1 min read
·
Annalee Armstrong
